FibroScan (Transient Elastography) and Shear Wave Elastography Perform Similarly for Liver Fibrosis Assessment
Both FibroScan (vibration-controlled transient elastography/VCTE) and shear wave elastography (SWE) demonstrate comparable diagnostic accuracy for staging liver fibrosis in adults with chronic liver disease, with neither technique showing clear superiority over the other. 1
Evidence from the Most Recent Guidelines
The 2025 AASLD systematic review analyzing 240 studies with over 61,000 patients found that both techniques show acceptable to outstanding accuracy across all fibrosis stages 1. Key performance metrics include:
- Sensitivity ranges: 51-95% for F2-4,70-100% for F3-4, and 60-100% for F4
- Specificity ranges: 36-100% for F2-4,74-100% for F3-4, and 67-99% for F4
- Accuracy improves progressively from detecting significant fibrosis (F2-4) to advanced fibrosis (F3-4) to cirrhosis (F4)
The largest body of evidence exists for transient elastography (FibroScan), making it the most validated technique in clinical practice 1. However, this reflects its earlier market introduction rather than superior performance.
Direct Head-to-Head Comparisons
Recent 2025 studies directly comparing these techniques show:
- Strong correlation between pSWE and VCTE (r = 0.838 vs 0.803 when compared to MRE as reference) 2
- Comparable AUROC values for all fibrosis stages 3
- Excellent agreement in NAFLD/MASLD patients (Spearman's r = 0.66-0.85) 4, 5
Practical Considerations for Clinical Use
When FibroScan May Be Preferred:
- More extensive validation data across diverse liver disease etiologies
- Standardized protocols and established cutoff values for different diseases
- Dedicated device with consistent methodology
- Better studied in clinical trials and guideline development 1
When Shear Wave Elastography May Be Preferred:
- Integration with standard ultrasound examination (no separate device needed)
- Real-time B-mode imaging allows targeted measurement avoiding vessels/artifacts
- May perform better in patients with severe steatosis (grade S3), where FibroScan shows reduced agreement 4
- Potentially closer alignment with MRE values for detecting early and advanced fibrosis 2
Important Caveats
Both techniques share similar limitations that affect accuracy:
- Inflammation/hepatitis causes falsely elevated readings
- Vascular congestion (heart failure, hepatic vein thrombosis)
- Recent food intake (should fast 3-4 hours)
- Obstructive cholestasis
- Obesity (though both have XL probes/techniques for this)
These confounders cause stiffness changes unrelated to fibrosis and must be considered when interpreting results 1.
Disease-Specific Cutoff Values
A critical point: cutoff values differ between techniques and must be disease-specific 1. You cannot use the same kPa threshold for FibroScan and SWE. For example, in NAFLD patients, optimal ElastPQ (pSWE) cutoffs are consistently lower than FibroScan cutoffs for the same fibrosis stage 5.
Bottom Line for Clinical Practice
Choose based on availability and local expertise rather than perceived superiority. If your institution has FibroScan, use it—the extensive validation data and established cutoffs make interpretation straightforward 1. If you have ultrasound-based SWE, it performs equivalently and offers the advantage of simultaneous anatomic imaging 2, 3.
For patients with severe steatosis (CAP >300 dB/m), consider that SWE may maintain better correlation with actual fibrosis 4. For all other scenarios, either technique is appropriate, but ensure you apply the correct disease-specific and technique-specific cutoff values.